双环醇片 | China Drugs ListBicyclol Tablets | China Drugs List
本页为公开参考信息，不构成医疗建议、处方或药品供应要约。请向持证专业人士确认当前批准情况、可获得性及适用性。
- 商品名
- 百赛诺Baisainuo
- 企业
- 北京协和药厂；中国医学科学院药物研究所研发Beijing Union Pharmaceutical Factory; developed by the Institute of Materia Medica, Chinese Academy of Medical Sciences.
- 药品类型
- 化学药Chemical medicine
- 治疗领域
- 消化科Gastroenterology
- 公开来源记录的适应症
- 用于治疗慢性肝炎所致的氨基转移酶升高。For elevated aminotransferase levels caused by chronic hepatitis.
- 适应症来源与口径
- 无法从原文件确认修订日期。The revision date could not be confirmed from the original file.
- 说明书信息局限
- 尚未取得可核实的完整药品说明书。现有批准记录或国家医保局申报资料支持所示适应症；最新完整范围尚待确认。A verifiable complete prescribing-information document has not yet been obtained. Available approval records or NHSA submissions support the indications shown; the latest full scope needs confirmation.
- 中国可获得性状态
- 已核实中国历史批准记录；尚未逐项核查每个产品目前是否持续上市销售。Historical Chinese approval verified; current continuous market availability has not been checked for every product.
- 海外状态
- 待逐一核查各市场。Market-by-market verification pending.
- 医保分类
- 已纳入国家医保（乙类）Included in national insurance (Category B)
- 医保版本
- 2025版；2026年1月1日起执行2025 edition; effective 1 January 2026
- 医保限制
- 该目录条目未另列限定；仍须遵守目录凡例及法定适应症No additional restriction is specified for this list entry; the list's general rules and approved indications still apply.
- 医保核查说明
- 按成分／剂型名称精确或标准化匹配。报销仍取决于剂型及目录所列支付限制。Matched by exact or normalized ingredient/formulation name. Reimbursement still depends on the dosage form and listed payment restrictions.